Stock data

永信 (3705)

永信 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$659.23M, up 8.7% from a year earlier. EPS over the last four quarters totals NT$3.37.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 永信 in Insightr